1-3 of 3
Yong-jiang Hei
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

An Open-Label, Multicenter, Phase Ib Study of the Anti-TIM3 Monoclonal Antibody BC3402 in Combination with Azacitidine in Patients with Higher-Risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)

Bing Li, Qing-song Yin, Xiaojing Yan, Min Hang, Hai-Jun Guo, Sheng Wang, Yi-wei Wang, Yong-jiang Hei, Zhi-jian Xiao
Journal: Blood
Blood (2024) 144 (Supplement 1): 4135.
https://doi.org/10.1182/blood-2024-201319
Published: 2024
Journal Articles

Baseline N-Telopeptide Levels Correlate with Risk of Skeletal Morbidity in Patients with Multiple Myeloma during Zoledronic Acid Therapy.

Allan Lipton, Robert E. Coleman, Pierre Major, Janet E. Brown, Ker-Ai Lee, Matthew Smith, Fred Saad, YinMiao Chen, Yong Jiang, Hei, Richard Cook
Journal: Blood
Blood (2005) 106 (11): 3456.
https://doi.org/10.1182/blood.V106.11.3456.3456
Published: 2005
Journal Articles

Prognostic Significance of Biochemical Markers of Bone Metabolism in Patients with Bone Lesions from Multiple Myeloma (MM).

Richard J. Cook, Robert E. Coleman, Pierre Major, Allan Lipton, Janet E. Brown, Ker-Ai Lee, Matthew Smith, Fred Saad, YinMiao Chen, Yong Jiang Hei
Journal: Blood
Blood (2005) 106 (11): 5015.
https://doi.org/10.1182/blood.V106.11.5015.5015
Published: 2005